Search Results - "Shoya Arakawa"

Minimization of adverse effects of blank matrices from various apparatuses in the downsizing of gas chromatography–mass spectrometry-based metabolomics by Arakawa, Shoya, Furuno, Masahiro, Fukusaki, Eiichiro

“…The ability to reduce sample volume required for gas chromatography–mass spectrometry (GC/MS) metabolome analyses is limited by the effects of blank matrices…”
Get full text

Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS by Omori, Kazuo, Katakami, Naoto, Arakawa, Shoya, Yamamoto, Yuichi, Ninomiya, Hiroyo, Takahara, Mitsuyoshi, Matsuoka, Taka-aki, Tsugawa, Hiroshi, Furuno, Masahiro, Bamba, Takeshi, Fukusaki, Eiichiro, Shimomura, Iichiro

“…Aim: An identification of the high-risk group of atherosclerotic cardiovascular disease (CVD) is important in the management of patients with diabetes…”
Get full text

The ATP-hydrolyzing ectoenzyme E-NTPD8 attenuates colitis through modulation of P2X4 receptor–dependent metabolism in myeloid cells by Tani, Haruka, Li, Bo, Kusu, Takashi, Okumura, Ryu, Nishimura, Junichi, Okuzaki, Daisuke, Motooka, Daisuke, Arakawa, Shoya, Mori, Asuka, Yoshihara, Terukazu, Ogino, Takayuki, Tsai, Shih-Han, Furuta, Yoki, Muneta, Masato, Nakamura, Shota, Fukusaki, Eiichiro, Yamamoto, Kimiko, Yagita, Hideo, Kayama, Hisako, Takeda, Kiyoshi

“…Extracellular adenosine triphosphate (ATP) released by mucosal immune cells and by microbiota in the intestinal lumen elicits diverse immune responses that…”
Get full text

Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry‐based non‐target metabolomic analysis by Taya, Naohiro, Katakami, Naoto, Omori, Kazuo, Arakawa, Shoya, Hosoe, Shigero, Watanabe, Hirotaka, Takahara, Mitsuyoshi, Miyashita, Kazuyuki, Nishizawa, Hitoshi, Matsuoka, Taka‐Aki, Furuno, Masahiro, Bamba, Takeshi, Iida, Junko, Fukusaki, Eiichiro, Shimomura, Iichiro

“…Aims/Introduction Diabetes patients develop a variety of metabolic abnormalities in addition to hyperglycemia. However, details regarding change in various…”
Get full text

Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes by Katakami, Naoto, Omori, Kazuo, Taya, Naohiro, Arakawa, Shoya, Takahara, Mitsuyoshi, Matsuoka, Taka-aki, Tsugawa, Hiroshi, Furuno, Masahiro, Bamba, Takeshi, Fukusaki, Eiichiro, Shimomura, Iichiro

“…Background Although an increased arterial stiffness has been associated with traditional coronary risk factors, the risk factors and pathology of arterial…”
Get full text

Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. - Findings from Metabolome Analysis Using GC/MS by Kazuo Omori, Naoto Katakami, Shoya Arakawa, Yuichi Yamamoto, Hiroyo Ninomiya, Mitsuyoshi Takahara, Taka-aki Matsuoka, Hiroshi Tsugawa, Masahiro Furuno, Takeshi Bamba, Eiichiro Fukusaki, Iichiro Shimomura

“…[Aim :] An identification of the high-risk group of atherosclerotic cardiovascular disease (CVD) is important in the management of patients with diabetes…”
Get full text

Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS by Omori, Kazuo, Katakami, Naoto, Arakawa, Shoya, Yamamoto, Yuichi, Ninomiya, Hiroyo, Takahara, Mitsuyoshi, Matsuoka, Taka-aki, Tsugawa, Hiroshi, Furuno, Masahiro, Bamba, Takeshi, Fukusaki, Eiichiro, Shimomura, Iichiro

“…Aim: An identification of the high-risk group of atherosclerotic cardiovascular disease (CVD) is important in the management of patients with diabetes…”
Get full text